45,202 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 45,202 shares of the company’s stock, valued at approximately $3,128,000.

A number of other institutional investors also recently bought and sold shares of HSIC. Holocene Advisors LP purchased a new stake in Henry Schein during the third quarter worth approximately $58,319,000. Southpoint Capital Advisors LP raised its holdings in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Henry Schein during the 3rd quarter worth approximately $43,740,000. Bank of Montreal Can boosted its holdings in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after buying an additional 558,689 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of Henry Schein in the 4th quarter valued at $34,720,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Up 0.5 %

Henry Schein stock opened at $69.75 on Thursday. The stock’s 50 day moving average price is $74.76 and its 200 day moving average price is $72.63. The company has a market cap of $8.66 billion, a PE ratio of 28.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.66 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research reports. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Insider Activity

In related news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.